MétaCan
Menu
Back to cohort
Record W2562798760 · doi:10.1016/s1525-0016(16)34059-x

450. A Single Immunization With Optimized DNA Vaccines Protects Against Lethal Ebola Virus Challenge in Mice and Induces Seroconversion in Non-Human Primates Following a DNA Prime–DNA Boost Approach

2015· article· en· W2562798760 on OpenAlexaff
Ami Patel, Emma L. Reuschel, Veronica L. Scott, Kimberly A. Kraynyak, Gary Wong, Daniel O. Villarreal, Muthumani Karuppiah, Devon J. Shedlock, Jian Yan, Kate E. Broderick, Amir Sada Khan, Kevin Tierney, Gary Wong, Niranjan Y. Sardesai, David B. Weiner

Bibliographic record

VenueMolecular Therapy · 2015
Typearticle
Languageen
FieldMedicine
TopicViral Infections and Outbreaks Research
Canadian institutionsUniversity of ManitobaPublic Health Agency of Canada
Fundersnot available
KeywordsVirologyDNA vaccinationImmunogenicityImmunizationEbola vaccineBiologyOutbreakEbola virusSeroconversionModified vaccinia AnkaraImmunologyVirusMedicineAntigenRecombinant DNAVacciniaGene

Abstract

fetched live from OpenAlex

Ebola is a hemorrhagic fever virus that is responsible for the severe, ongoing outbreak in West Africa, with over 21000 confirmed cases and a mortality rate of >39%. Control of the outbreak has been a considerable challenge as there are no approved vaccines or therapies. Recent reports suggest that the outbreak is more severe than previously thought and investigating alternative immunization approaches would be of great benefit. We generated 3 DNA vector vaccine candidates expressing the Zaire ebolavirus (EBOV) glycoprotein (GP): 2 vaccines designed based on consensus sequences of EBOV GPs (1976-2014) and a 3rd matched construct to a 2014 Guinea strain. Immunogenicity and protection was first evaluated in mice, followed by studies in non-human primates (NHP). BALB/c mice received a single immunization of each DNA vaccine (40mg), delivered by intramuscular injection followed by electroporation (IM-EP). We also co-administered 2 or 3 construct formulations of DNA vaccines as an alternative strategy to broaden efficacy against antigenically distant EBOV strains. All 3 single and all co-formulated vaccines generated strong T cell responses, including GP-specific polyfunctional CD4+ and CD8+ T cells secreting IFNγ, TNFα, and IL2. BALB/c mice (n=10/group) were challenged with a lethal dose of a heterologous mouse-adapted Mayinga 1976 EBOV strain. The two consensus DNA vaccines and 2 and 3 vaccine combinations were 100% protective in mice. The matched vaccine afforded 90% protection. Total GP-specific IgG levels were high in all surviving mice and low in unprotected animals suggesting that titers may correlate with therapeutic efficacy. As all 3 DNA vaccines were immunogenic and no antigen interference was observed, we next investigated immunogenicity of the 3 DNA vaccines in rhesus macaques following a DNA-DNA prime-boost immunization regimen. Macaques (n=5/group) received by IM-EP delivery:1) matched vaccine (4mg), 2) 3-construct formulation administered at a single injection site (2mg/vaccine), 3) 3-construct formulation delivered at separate injection sites (2mg/vaccine), or 4) 3-construct formulation combined with IL12 adjuvant (2mg/vaccine). Each immunization was followed by 3 subsequent DNA boosts at 1 month intervals. All groups had high GP-specific total IgG titers post-1st boost immunization that continued to increase over subsequent boosts and detectable T-cell responses. Overall, these studies demonstrate that a DNA-DNA prime-boost regimen can effectively induce seroconversion in NHPs and further studies will serve to evaluate protective immunogenicity. This approach not only serves as a tool to better understand the immune responses associated with protection against EBOV infection, but also has potential for translation towards human applications.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.021
Threshold uncertainty score0.801

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.031
GPT teacher head0.298
Teacher spread0.267 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueMolecular TherapySame topicViral Infections and Outbreaks ResearchFrench-language works237,207